StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.

The Novo Nordisk drug was compared to Trulicity in its SUSTAIN 7 trial ... Once approved, this oral version could open up a much bigger diabetes market, as the need to inject GLP-1 drugs still ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...

Diabetes medications like Ozempic and Trulicity are typically covered, while weight loss drugs like Wegovy and Saxenda face limited coverage unless specific health criteria are met. Ren-Fielding ...

that will be used to produce injectable drugs and devices, supporting products like GLP-1 agonist Trulicity (dulaglutide) and dual GIP/GLP-1 agonist Mounjaro (tirzepatide) for diabetes ...

Co.’s Trulicity. The researchers didn’t compare the Novo drugs with Lilly’s newer diabetes shot, Mounjaro. With assistance from Madison Muller.

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

Metformin, a chemical relative of that compound, has been a top type 2 diabetes treatment in the United States since it was approved in 1994. It’s cheap—less than a dollar per dose—and readily ...

Thousands of Americans are diagnosed with Type 1 diabetes every year, according to the American Diabetes Association. But a new medication now available worldwide has the potential to drive that ...